Investor profile
SR One has backed 5 European tech companies across 5 funding rounds between 2015 and 2025, joining rounds totalling €247M. Most active in Healthtech and AI. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Antag Therapeutics | Denmark | 1 | €80M |
| Charm Therapeutics | UK | 1 | €69M |
| CRISPR Therapeutics | Switzerland | 1 | €59M |
| Pulmocide | UK | 1 | €28M |
| MISSION Therapeutics | UK |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Antag Therapeutics | Series A | €80M | 2024-12 |
| Charm Therapeutics | Series B | €69M | 2025-09 |
| CRISPR Therapeutics | Series B | €59M | 2015-04 |
| Pulmocide |
| 1 |
| €11M |
| Series B |
| €28M |
| 2017-03 |
| MISSION Therapeutics | Other | €11M | 2025-10 |
